CCL4 and COVID-19: Within a week of diagnosis, individuals who developed asymptomatic or mild COVID-19 could be distinguished by significantly increased mucosal IP-10 and decreased systemic IL-1RA, MIP-1β, IL-6, fractalkine, IgA, and IgM within one week of positive diagnostic (Fig. 6A and C).